Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VOLITIONRX LTDVNRX · Entity 8241 | Director | February 11, 2019 | February 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VOLITIONRX LTD
Report date February 11, 2019 · Filed February 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.25 · Expires 2025-02-11 | Direct | 15,000 |
Reported balance
After 2019-02-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-02-11 · Grant · Acquired 15,000 · Balance 15,000 F1: A total of 15,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: A total of 15,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2019 Filed Feb 13, 2019 21:43 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001078782-19-000133 · primary_doc.xml · derivative · entry 1 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2025-02-11 F1 · derivative.exercise_date: A total of 15,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:26 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantOption (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-001444 · primary_doc.xml · derivative · entry 6 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2021-07-23 F2 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015 and vested in full at 6 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2021. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:26 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Disposition to issuerOption (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-001444 · primary_doc.xml · derivative · entry 5 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-01-23 F2 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015 and vested in full at 6 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2021. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:26 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantOption (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-18-001444 · primary_doc.xml · derivative · entry 4 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2020-08-18 F1 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:26 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantOption (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-18-001444 · primary_doc.xml · derivative · entry 3 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2020-08-18 F1 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:26 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Disposition to issuerOption (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-18-001444 · primary_doc.xml · derivative · entry 2 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2020-02-18 F1 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:26 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Disposition to issuerOption (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-18-001444 · primary_doc.xml · derivative · entry 1 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2019-02-18 F1 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 21:21 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000066 · primary_doc.xml · derivative · entry 1 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 10,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:33 UTC | VOLITIONRX LTD VNRX · Entity 8241 | OtherWarrant (Right to Buy) · Derivative | 3,143 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001078782-17-000604 · primary_doc.xml · derivative · entry 2 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,143 shares Expires 2017-05-10 F1 · derivative.underlying_shares: On May 5, 2017, the Reporting Person exercised a warrant to purchase 3,143 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:33 UTC | VOLITIONRX LTD VNRX · Entity 8241 | OtherCommon Stock | 3,143 | $2.60 | $8,171.80 |
DisclosureSEC source: 0001078782-17-000604 · primary_doc.xml · nonDerivative · entry 1 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,542 F1 · balance_after: On May 5, 2017, the Reporting Person exercised a warrant to purchase 3,143 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:17 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000408 · primary_doc.xml · derivative · entry 1 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 15,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:52 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-16-003789 · primary_doc.xml · derivative · entry 3 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2016-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:52 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Tax withholdingCommon Stock | 2,791 | $4.30 | $12,001.30 |
DisclosureSEC source: 0001078782-16-003789 · primary_doc.xml · nonDerivative · entry 2 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,399 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:52 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Exercise / conversionCommon Stock | 4,000 | $3.00 | $12,000.00 |
DisclosureSEC source: 0001078782-16-003789 · primary_doc.xml · nonDerivative · entry 1 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.